Patents by Inventor Mehmet Pisak

Mehmet Pisak has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 9283220
    Abstract: Provided are compositions comprising opioid antagonists, such as naltrexone naloxone, or nalmefene, or their pharmaceutically acceptable salts, and methods for treating conditions caused by the varicella-zoster virus therewith.
    Type: Grant
    Filed: March 31, 2011
    Date of Patent: March 15, 2016
    Assignee: IMUNEKS FARMA ILAC SANAYI VE TICARET ANONIM SIRKETI PAK IS MERKEZI
    Inventors: Ibrahim Mustafa Iskender Pisak, Semra Bingol, Mehmet Levent Selamoglu, Mehmet Pisak
  • Publication number: 20120252831
    Abstract: Provided are compositions comprising opioid antagonists, such as naltrexone naloxone, or nalmefene, or their pharmaceutically acceptable salts, and methods for treating scleroderma, including systemic sclerosis, therewith.
    Type: Application
    Filed: March 31, 2011
    Publication date: October 4, 2012
    Applicant: Mustafa Nevzat Ilac Sanayii A.S.
    Inventors: Ibrahim Mustafa Iskender Pisak, Semra Bingol, Mehmet Levent Selamoglu, Mehmet Pisak
  • Publication number: 20110245278
    Abstract: Provided are compositions comprising opioid antagonists, such as naltrexone naloxone, or nalmefene, or their pharmaceutically acceptable salts, and methods for treating conditions caused by the varicella-zoster virus therewith.
    Type: Application
    Filed: March 31, 2011
    Publication date: October 6, 2011
    Applicant: Mustafa Nevzat Ilac Sanayii A.S.
    Inventors: Ibrahim Mustafa Iskender Pisak, Semra Bingol, Mehmet Levent Selamoglu, Mehmet Pisak